ヒップリン酸メセナミン錠剤の世界市場レポート 2025年

ヒップリン酸メセナミン錠剤市場規模は、今後数年間で力強い成長が見込まれます。2029年には137億8,000万米ドルに成長し、CAGRは7.8%となります。予測期間の成長は、UTI有病率の増加、抗生物質耐性に関する懸念の高まり、UTI管理の進歩、予防療法に対するヘルスケアの注力、臨床試験および調査に起因すると考えられます。予測期間における主な動向は、UTI罹患率の増加、抗生物質耐性の上昇、非抗生物質治療への嗜好、予防医療への注力、研究開発などです。

高齢者人口の増加が予想されることから、今後数年間はヒップリン酸メセナミン錠剤市場の成長が見込まれます。老年人口は60歳以上で構成され、尿流量の減少、前立腺肥大、腎臓結石などの要因により尿路感染症にかかりやすくなっています。その結果、これらの症状を治療するためのヒップリン酸メセナミン錠剤の需要が高まると予想されます。例えば、世界保健機関（WHO）の報告によると、2030年までに世界の65歳以上人口の割合は、2022年の10％から2050年には16％に上昇すると予想されています。このように、2050年までに老年人口が増加することは、ヒップリン酸メセナミン錠剤市場成長の主要な促進要因であると予測されています。

尿路感染症（UTI）の発生率の増加が、ヒップリン酸メセナミン錠剤市場の今後の成長を牽引すると予測されています。尿路感染症は、細菌が尿道に侵入し、尿路に感染することで発生する一般的な疾患であり、一般的には皮膚や直腸から発生します。ヒップリン酸メセナミン錠剤は、特定の細菌によって引き起こされる尿路感染症の予防や治療に利用されています。例えば、2023年10月、英国の政府部門であるNational Health Serviceは、2022/23年の間に、尿路結石を主診断とする入院が147,285件あったと報告しました。このうち、56％（82,392人）が65歳以上の高齢者であり、最も多かったのは80～84歳の17,280人でした。このように、尿路感染症の有病率の上昇が、ヒプリン酸メセナミン市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ヒップリン酸メセナミン錠剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のヒップリン酸メセナミン錠剤市場：成長率分析
• 世界のヒップリン酸メセナミン錠剤市場の実績：規模と成長, 2019-2024
• 世界のヒップリン酸メセナミン錠剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界ヒップリン酸メセナミン錠剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒップリン酸メセナミン錠剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 20錠またはボトル
• 6錠またはボトル
• 世界のヒップリン酸メセナミン錠剤市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のヒップリン酸メセナミン錠剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単純性尿路感染症
• 医療関連UTI
• 世界のヒップリン酸メセナミン錠剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他エンドユーザー
• 世界のヒップリン酸メセナミン錠剤市場、タイプ別に20錠/ボトルのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準パッケージ
• バルクパッケージオプション
• 世界のヒップリン酸メセナミン錠剤市場、タイプ別にボトルあたり6錠のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準パッケージ
• サンプルまたは試用パッケージ

第7章 地域別・国別分析

• 世界のヒップリン酸メセナミン錠剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のヒップリン酸メセナミン錠剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒップリン酸メセナミン錠剤市場：競合情勢
• ヒップリン酸メセナミン錠剤市場：企業プロファイル
  • Alvogen Lux Holdings S.AR.L. Overview, Products and Services, Strategy and Financial Analysis
  • Micro Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Amneal Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• McKesson Corporation
• Sun Pharmaceutical Industries Ltd.
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cadila Healthcare Ltd.
• Torrent Pharmaceuticals Ltd.
• Glenmark Pharmaceuticals Ltd.
• Zydus Pharmaceuticals Ltd.
• Lupin Ltd.
• Alkem Laboratories Ltd.
• Ipca Laboratories Ltd.
• Granules India Ltd.
• Teva Pharmaceutical Industries Ltd.
• Apotex Pharmachem Inc.
• Sandoz International GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヒップリン酸メセナミン錠剤市場2029：新たな機会を提供する国
• ヒップリン酸メセナミン錠剤市場2029：新たな機会を提供するセグメント
• ヒップリン酸メセナミン錠剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Methenamine hippurate tablets serve as a medication for preventing or controlling recurring urinary tract infections caused by specific bacteria. However, it is not used for treating active infections.

The main types of methenamine hippurate tablets are available in two forms, 20 tablets per bottle and 6 tablets per bottle. Patients can access methenamine hippurate tablets in the form of a 20-tablet bottle. These tablets are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. The applications for these tablets include uncomplicated urinary tract infections (UTIs) and healthcare-associated UTIs. The end users encompass hospitals, homecare settings, specialty clinics, and others.

The methenamine hippurate tablets market research report is one of a series of new reports from The Business Research Company that provides methenamine hippurate tablets market statistics, including methenamine hippurate tablets industry global market size, regional shares, competitors with methenamine hippurate tablets market share, detailed methenamine hippurate tablets market segments, market trends, and opportunities, and any further data you may need to thrive in the methenamine hippurate tablets industry. This methenamine hippurate tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The methenamine hippurate tablets market size has grown strongly in recent years. It will grow from $9.52 billion in 2024 to $10.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to traditional UTI treatment, antibiotic resistance concerns, clinical validation, physician prescription patterns, patient preference for non-antibiotic solutions.

The methenamine hippurate tablets market size is expected to see strong growth in the next few years. It will grow to $13.78 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing UTI prevalence, rising antibiotic resistance concerns, advancements in UTI management, healthcare focus on preventive therapies, clinical trials and research. Major trends in the forecast period include increased UTI incidence, rising antibiotic resistance, preference for non-antibiotic treatments, focus on preventive healthcare, research and development.

The anticipated increase in the geriatric population is poised to drive the growth of the methenamine hippurate tablets market in the coming years. The geriatric population comprises individuals aged 60 and above, who are more susceptible to urinary tract infections due to factors such as reduced urine flow, enlarged prostate, or kidney stones. Consequently, the demand for methenamine hippurate tablets for treating these conditions is expected to rise. For instance, the World Health Organization reports that by 2030, the percentage of the global population aged 65 and above is expected to rise from 10% in 2022 to 16% in 2050. It is projected that by 2050, Thus, the increasing geriatric population is a key driver for the growth of the methenamine hippurate tablets market.

The increasing incidence of urinary tract infections (UTIs) is projected to drive the growth of the methenamine hippurate tablets market in the future. UTIs are common conditions that arise when bacteria enter the urethra and infect the urinary tract, typically originating from the skin or rectum. Methenamine hippurate tablets are utilized to prevent or treat recurring urinary tract infections caused by specific bacteria. For instance, in October 2023, the National Health Service, a UK-based government department, reported that during the 2022/23 period, there were 147,285 admissions for UTIs as the primary diagnosis. Among these, 56% (82,392) were individuals aged 65 and older, with the highest number of admissions occurring in the 80-84 age group, which accounted for 17,280 admissions. Thus, the rising prevalence of urinary tract infections is fueling the growth of the methenamine hippurate market.

Product innovations have become a significant trend gaining traction in the methenamine hippurate tablets market. Leading companies in this sector are developing innovative products to enhance their market position. For example, in May 2023, EQL Pharma, a European pharmaceutical company specializing in cost-effective generic medicines and niche generics for pharmacies and hospitals, announced the out-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle for distribution in the French market. This move expands the availability of Memprex and provides a non-antibiotic option for UTI prevention. Laboratoires Majorelle, a prominent player in women's health in France, will market and distribute Memprex, offering an alternative for preventing urinary tract infections.

Strategic collaborations have become a significant avenue for major companies operating in the methenamine hippurate tablets market to enhance profitability. These collaborations involve purposeful partnerships between entities to achieve mutual goals through coordinated efforts, leveraging each other's strengths and resources. In May 2023, EQL Pharma AB, a Swedish pharmaceutical company providing methenamine hippurate tablets, entered into a collaboration with Dr. Pfleger Arzneimittel GmbH. Through this collaboration, EQL Pharma AB aims to launch Methenamine Hippurate with an EQL-registered brand within the next two years, involving standard license fees, regulatory and reimbursement milestones, and a volume-dependent supply price upon regulatory approval. Dr. Pfleger Arzneimittel GmbH is a German pharmaceutical company.

In April 2022, Aurelius Group, a German asset management company, acquired McKesson UK for an undisclosed amount. This acquisition is intended to support growth and development across retail, digital, homecare, and wholesale divisions, expanding the healthcare system to enhance patient outcomes. McKesson UK is a UK-based healthcare company providing methenamine hippurate tablets.

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.AR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the methenamine hippurate tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The methenamine hippurate tablets market consists of sales of hexamine hippurate tablets, hiprex tablets, and urinary tract infection tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Methenamine Hippurate Tablets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on methenamine hippurate tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for methenamine hippurate tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The methenamine hippurate tablets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 20 Tablets Or Bottle; 6 Tablets Or Bottle
• 2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 3) By Application: Uncomplicated UTIs; Healthcare-associated UTIs
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Others End Users
• Subsegments:
• 1) By 20 Tablets per Bottle: Standard Packaging; Bulk Packaging Options
• 2) By 6 Tablets per Bottle: Standard Packaging; Sample Or Trial Packaging
• Companies Mentioned: Alvogen Lux Holdings S.AR.L.; Micro Labs Inc.; Aurobindo Pharma; Amneal Pharmaceuticals Inc.; Viatris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Methenamine Hippurate Tablets Market Characteristics

3. Methenamine Hippurate Tablets Market Trends And Strategies

4. Methenamine Hippurate Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Methenamine Hippurate Tablets Growth Analysis And Strategic Analysis Framework

• 5.1. Global Methenamine Hippurate Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Methenamine Hippurate Tablets Market Growth Rate Analysis
• 5.4. Global Methenamine Hippurate Tablets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Methenamine Hippurate Tablets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Methenamine Hippurate Tablets Total Addressable Market (TAM)

6. Methenamine Hippurate Tablets Market Segmentation

• 6.1. Global Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20 Tablets Or Bottle
• 6 Tablets Or Bottle
• 6.2. Global Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.3. Global Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Uncomplicated UTIs
• Healthcare-associated UTIs
• 6.4. Global Methenamine Hippurate Tablets Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Others End Users
• 6.5. Global Methenamine Hippurate Tablets Market, Sub-Segmentation Of 20 Tablets per Bottle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Packaging
• Bulk Packaging Options
• 6.6. Global Methenamine Hippurate Tablets Market, Sub-Segmentation Of 6 Tablets per Bottle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Packaging
• Sample Or Trial Packaging

7. Methenamine Hippurate Tablets Market Regional And Country Analysis

• 7.1. Global Methenamine Hippurate Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Methenamine Hippurate Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Methenamine Hippurate Tablets Market

• 8.1. Asia-Pacific Methenamine Hippurate Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Methenamine Hippurate Tablets Market

• 9.1. China Methenamine Hippurate Tablets Market Overview
• 9.2. China Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Methenamine Hippurate Tablets Market

• 10.1. India Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Methenamine Hippurate Tablets Market

• 11.1. Japan Methenamine Hippurate Tablets Market Overview
• 11.2. Japan Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Methenamine Hippurate Tablets Market

• 12.1. Australia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Methenamine Hippurate Tablets Market

• 13.1. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Methenamine Hippurate Tablets Market

• 14.1. South Korea Methenamine Hippurate Tablets Market Overview
• 14.2. South Korea Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Methenamine Hippurate Tablets Market

• 15.1. Western Europe Methenamine Hippurate Tablets Market Overview
• 15.2. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Methenamine Hippurate Tablets Market

• 16.1. UK Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Methenamine Hippurate Tablets Market

• 17.1. Germany Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Methenamine Hippurate Tablets Market

• 18.1. France Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Methenamine Hippurate Tablets Market

• 19.1. Italy Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Methenamine Hippurate Tablets Market

• 20.1. Spain Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Methenamine Hippurate Tablets Market

• 21.1. Eastern Europe Methenamine Hippurate Tablets Market Overview
• 21.2. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Methenamine Hippurate Tablets Market

• 22.1. Russia Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Methenamine Hippurate Tablets Market

• 23.1. North America Methenamine Hippurate Tablets Market Overview
• 23.2. North America Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Methenamine Hippurate Tablets Market

• 24.1. USA Methenamine Hippurate Tablets Market Overview
• 24.2. USA Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Methenamine Hippurate Tablets Market

• 25.1. Canada Methenamine Hippurate Tablets Market Overview
• 25.2. Canada Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Methenamine Hippurate Tablets Market

• 26.1. South America Methenamine Hippurate Tablets Market Overview
• 26.2. South America Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Methenamine Hippurate Tablets Market

• 27.1. Brazil Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Methenamine Hippurate Tablets Market

• 28.1. Middle East Methenamine Hippurate Tablets Market Overview
• 28.2. Middle East Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Methenamine Hippurate Tablets Market

• 29.1. Africa Methenamine Hippurate Tablets Market Overview
• 29.2. Africa Methenamine Hippurate Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Methenamine Hippurate Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Methenamine Hippurate Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Methenamine Hippurate Tablets Market Competitive Landscape And Company Profiles

• 30.1. Methenamine Hippurate Tablets Market Competitive Landscape
• 30.2. Methenamine Hippurate Tablets Market Company Profiles
  • 30.2.1. Alvogen Lux Holdings S.AR.L. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Micro Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amneal Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Methenamine Hippurate Tablets Market Other Major And Innovative Companies

• 31.1. McKesson Corporation
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Cipla Ltd.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Cadila Healthcare Ltd.
• 31.6. Torrent Pharmaceuticals Ltd.
• 31.7. Glenmark Pharmaceuticals Ltd.
• 31.8. Zydus Pharmaceuticals Ltd.
• 31.9. Lupin Ltd.
• 31.10. Alkem Laboratories Ltd.
• 31.11. Ipca Laboratories Ltd.
• 31.12. Granules India Ltd.
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Apotex Pharmachem Inc.
• 31.15. Sandoz International GmbH

32. Global Methenamine Hippurate Tablets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Methenamine Hippurate Tablets Market

34. Recent Developments In The Methenamine Hippurate Tablets Market

35. Methenamine Hippurate Tablets Market High Potential Countries, Segments and Strategies

• 35.1 Methenamine Hippurate Tablets Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Methenamine Hippurate Tablets Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Methenamine Hippurate Tablets Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer